• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » SARS-CoV-2

Articles Tagged with ''SARS-CoV-2''

Other news to note for June 25, 2020

June 25, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aeterna Zentaris, Aldevron, Applied Biology, Aptevo, Aspire, Asterias, Atrogi, Catalent, Crispr Therapeutics, Edge, Emergent, Entos, Everinsight, Hemostemix, Immuneering, Intensity, La Jolla, Lineage, Megapharm, Melinta, Moderna, Moleculin, Neurovation, Nurix, Onxeo, Otsuka, Pfizer, Reneuron, Sanifit, Seelos, Simcha, Tetraphase, Vaxart, Vistagen, Ziopharm.
Read More

Regulatory actions for June 24, 2020

June 24, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Gencurix.
Read More

Other news to note for June 24, 2020

June 24, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avacta Group, Biocept, Caremindr, Cortechs, Cytiva, Docbot, Erba Mannheim, Fluidigm, Global Wholehealth Partners, Incontext.ai, Integrated Genetics, Life Image, PCORI, RapidAI, Senzime, Smiths Medical, Subtle Medical, Sugarmate, Tandem Diabetes Care, Windtree Therapeutics.
Read More
Ziva instrument in the lab

Adarza’s Ziva provides window into immune response to COVID-19 and other pathogens

June 23, 2020
By Annette Boyle
Adarza Biosystems Inc.’s Ziva platform can simultaneously detect hundreds of proteins, antibodies, or substrates from a single drop of blood, plasma or serum, providing insight into an individual’s immune response. That could be critical for both surveillance and diagnostic purposes as the nation prepares for a likely second wave of the novel coronavirus in the fall when multiple respiratory pathogens will be circulating.
Read More
U.S. Capitol building

Witnesses at Senate hearing press for annual appropriation for vaccine infrastructure

June 23, 2020
By Mark McCarty
The Senate Health, Education, Labor and Pensions (HELP) Committee met again June 23 to discuss the federal government response to the COVID-19 pandemic, and one clear signal that emerged from the hearing is that Congress will have to provide annual funding to build a sustainable infrastructure for vaccine development and manufacture if the nation is to deal appropriately with the next pandemic.
Read More
RNA and SARS-CoV-2 virus cell

Translate Bio stock rockets as Sanofi expands into mRNA platform for vaccines

June 23, 2020
By Cormac Sheridan
DUBLIN – Translate Bio Inc. is the first beneficiary to gain from Sanofi SA’s massive $11.7 billion addition to its balance sheet, following its recent disposal of its holdings in long-time partner Regeneron Pharmaceuticals Inc. Lexington, Mass.-based Translate Bio is getting $300 million up front, another $125 million in equity investment and up to $1.9 billion in milestones under a major expansion of an existing agreement with Paris-based Sanofi to develop mRNA-based vaccines for infectious disease.
Read More

Other news to note for June 23, 2020

June 23, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apple, Archerdx, Artegraft, Bertin Instruments, Bioskryb, Brite-Strike Technologies, Demetech, Golden Vine International, Hawkeye Systems, Illumina, Inovio Pharmaceuticals, Illumina, Invictus Medical, Invitae, Invo Bioscience, Karten Design, Lemaitre Vascular, Litecure, Mbio Diagnostics, Misty Robotics, Myocardial Solutions, Nano-X Imaging, Northeast Scientific, Ocutrx Vision Technologies, Pathgroup, Pathogendx, Qiagen, Sengenics, Transenterix, Vitanova Biomedical, Xatek, Zimmer Biomet.
Read More

Other news to note for June 22, 2020

June 22, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agena Bioscience, Avita, Astrazeneca, Caprion-Histogenex, Clinical Logistics, Gendius, Lantheus, Mevion, Microdermics, Natera, National Jewish Health, Novateur Ventures, Nuprobe, Orfit, Progenics, Qualtrics, Thermo Fisher Scientific, Weigao Group.
Read More
Product image
Group testing for COVID-19

Stilla introduces new approach to highly sensitive COVID-19 group testing using digital PCR

June 19, 2020
By Bernard Banga
PARIS – Stilla Technologies SAS, of Villejuif, France, is supplying a new, cost-effective approach for COVID-19 testing by combining its digital polymerase chain reaction (PCR) technology with the group testing method. “This approach greatly increases testing capacity and meets the highest quality standards,” Rémi Dangla, co-founder and CEO of Stilla Technologies, told BioWorld.
Read More
Lexagene CEO in lab

Lexagene's multiplex test gives answers needed to manage second wave of COVID-19

June 18, 2020
By Annette Boyle
Beverly, Mass.-based Lexagene Holdings Inc. has developed a genetic analyzer with multiplex testing capability that would enable it to determine whether a patient has COVID-19, influenza or another respiratory infection with one sample. The Lx Analyzer uses a proprietary quantitative reverse transcription polymerase chain reaction (RT-qPCR) method to automatically test for up to 27 pathogens simultaneously, all in about one hour.
Read More
Previous 1 2 … 108 109 110 111 112 113 114 115 116 … 134 135 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 10, 2025.
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • 3D rendering of a molecular glue mediating the interaction between two proteins

    With surface mimicry, molecular glues shed hairpin need

    BioWorld Science
    Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe